HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multisystem inflammatory syndrome in adults (MIS-A) following COVID-19 requiring venoarterial extracorporeal membrane oxygenation.

Abstract
The SARS-CoV-2 virus has caused a global pandemic with serious impact around the world. Patients most commonly present with severe lung involvement and acute respiratory failure; however, multisystem inflammatory syndrome in adults (MIS-A) is a known-although rare-complication. We present a case of a 49-year-old patient who presented with combined cardiogenic and vasodilatory shock and was diagnosed with MIS-A. He initially required venoarterial extracorporeal membrane oxygenation and Impella for haemodynamic support but was able to be weaned off these devices with complete recovery of left ventricular systolic function. This case demonstrates that MIS-A may present as haemodynamic collapse in adults, but complete recovery is possible with proper haemodynamic support.
AuthorsSeth Newman, Fengwei Zou, Shivank Madan, Daniel Sims
JournalBMJ case reports (BMJ Case Rep) Vol. 15 Issue 3 (Mar 07 2022) ISSN: 1757-790X [Electronic] England
PMID35256368 (Publication Type: Case Reports, Journal Article)
Copyright© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Topics
  • Adult
  • COVID-19
  • Extracorporeal Membrane Oxygenation (adverse effects)
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2
  • Shock, Cardiogenic (diagnosis, etiology, therapy)
  • Systemic Inflammatory Response Syndrome (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: